Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005 Oct;48(5):1204-35.
Tyler RS. Tinnitus hand book of medicine. San Diego, CA: Singular Publishing Group; 2000.
Cima RF, Maes IH, Joore MA, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9.
Muehlmeier G, Biesinger E, Maier H. Safety of intratympanic injection of AM-101 in patients with acute inner ear tinnitus. Audiol Neurootol. 2011;16(6):388-97.
1. Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005 Oct;48(5):1204-35.
2. Noell CA, Meyerhoff WL. Tinnitus. Diagnosis and treatment of this elusive symptom. Geriatrics. 2003 Feb;58(2):28-34.
3. Tyler RS. Tinnitus hand book of medicine. San Diego, CA: Singular Publishing Group; 2000.
4. Sanchez L. The epidemiology of tinnitus. Audiological Medicine. 2004;2:8-17.
5. Seidman MD, Standring RT, Dornhoffer JL. Tinnitus: current understanding and contemporary management. Curr Opin Otolaryngol Head Neck Surg. 2010 Oct;18(5):363-8.
6. Seidman MD, Jacobson GP. Update on tinnitus. Otolaryngol Clin North Am. 1996 Jun;29(3):455-65.
7. Seidman MD, Babu S. Alternative medications and other treatments for tinnitus: facts from fiction. Otolaryngol Clin North Am. 2003 Apr;36(2):359-81.
8. Seidman MD, DeRidder DD, Elisevich K, et al. Direct electrical stimulation of Heschl's gyrus for tinnitus treatment. Laryngoscope. 2008 Mar;118(3):491-500.
9. Crummer RW, Hassan GA. Diagnostic approach to tinnitus. Am Fam Physician. 2004 Jan 1;69(1):120-6.
10. Seidman MD, Arenberg AG, Shirwany NA. Palatal myoclonus as a cause of objective tinnitus: a report of six cases and a review of the literature. Ear Nose Throat J. 1999 Apr;78(4):292-7.
11. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990 Aug;8(4):221-54.
12. Eggermont JJ. On the pathophysiology of tinnitus: a review and peripheral model. Hear Res. 1990 Sep;48(1-2):111-23.
13. Guitton MJ, Caston J, Ruel J, et al. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci. 2003 May 1;23(9):3944-52.
14. LePage EL. A model for cochlear origin of subjective tinnitus: excitatory drift in the operating point of inner hair cells. In: Vernon JA, Moller AR, eds. Mechanisms of tinnitus. London: Allyn and Bacon; 1995:115-48.
15. Sahley TL, Nodar RH. A biochemical model of peripheral tinnitus. Hear Res. 2001 Feb;152(1-2):43-54.
16. Khan MJ, Seidman MD, Quirk WS, et al. Effects of kynurenic acid as a glutamate receptor antagonist in the guinea pig. Eur Arch Otorhinolaryngol. 2000;257(4):177-81.
17. Seidman MD, Van de Water T. Pharmacologic manipulation of the labyrinth with novel and traditional agents delivered to the inner ear. Ear Nose Throat J. 2003 Apr;82(4):276-88.
18. Moller AR. Pathophysiology of tinnitus. Ann Otol Rhinol Laryngol. 1984 Jan-Feb;93(1 Pt 1):39-44.
19. Kiang NY, Moxon EC, Levine RA. Auditory-nerve activity in cats with normal and abnormal cochleas. In: Sensorineural hearing loss. Ciba Found Symp. 1970:241-73.
20. Eggermont JJ. Tinnitus: some thoughts about its origin. J Laryngol Otol. 1984;(Suppl 9):31-7.
21. Wiederhold ML, Kiang NY. Effects of electric stimulation of the crossed olivocochlear bundle on single auditory-nerve fibers in the cat. J Acoust Soc Am. 1970 Oct;48(4):950-65.
22. Hazell JW. A cochlear model for tinnitus. In Feldmann H, ed. Proceedings of the 3rd International Tinnitus Seminar, Münster. Karlsruhe, Germany: Harsch;1987:121-8.
23. Brozoski TJ, Bauer CA, Caspary DM. Elevated fusiform cell activity in the dorsal cochlear nucleus of chinchillas with psychophysical evidence of tinnitus. J Neurosci. 2002 Mar 15;22(6):2383-90.
24. Cacace AT. Expanding the biological basis of tinnitus: crossmodal origins and the role of neuroplasticity. Hear Res. 2003 Jan;175(1-2):112-32.
25. Lockwood AH, Salvi RJ, Coad ML, et al. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology. 1998 Jan;50(1):114-20.
26. Zhang JS, Guan AL, Zhang XG, et al. Cortical electrical suppression of tinnitus and modulation of its related neural activity. In: Searchfield GD, Goodey R, eds. Proceedings of 'tinnitus discovery': Asia-pacific Tinnitus Symposium, 11-12 Sept 2009, Auckland, New Zealand. N Z Med J. 2010 Mar 19;123(1311):84.
27. Sindhusake D, Golding M, Newall P, et al. Risk factors for tinnitus in a population of older adults: The Blue Mountains hearing study. Ear Hear. 2003 Dec;24(6):501-7.
28. American College of Radiology. ACR appropriateness criteria: tinnitus. 2017 [internet publication].
29. Henry JA, Zaugg TL, Schechter MA. Clinical guide for audiologic tinnitus management I: assessment. Am J Audiol. 2005 Jun;14(1):21-48.
30. Song JJ, De Ridder D, Van de Heyning P, et al. Mapping tinnitus-related brain activation: an activation-likelihood estimation metaanalysis of PET studies. J Nucl Med. 2012 Oct;53(10):1550-7.
31. Bowyer SM, Seidman MD, Moran JE, et al. Coherence analysis of brain activity associated with tinnitus. In: Yokosawa K, ed. Biomagnetism-transdisciplinary research and exploration: proceedings of the 16th International Conference on Biomagnetism, Sapporo, Japan, August 25-29, 2008; in press.
32. Seidman MD, Khan MJ. The current status and trends of endolymphatic sac surgery among members of the American Neurotologic Society, American Otological Society, and Prosper Meniere Society. In: Arenberg IK, ed. Treatment options for Meniere’s disease: endolymphatic sac surgery: do it or don't do it and why? London: Singular Publishing Group, Inc. 1998:25-32.
33. Weissman JL, Hirsch BE. Imaging of tinnitus: a review. Radiology. 2000 Aug;216(2):342-9.
34. Brown RD Jr, Wiebers DO, Nichols DA. Intracranial dural arteriovenous fistulae: angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg. 1994 Oct;81(4):531-8.
35. Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. 2008 Mar;8(2):87-93.
36. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003 May 13;60(9):1418-24.
37. Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007 Apr;143(4):635-41.
38. Bateman GA. Association between arterial inflow and venous outflow in idiopathic and secondary intracranial hypertension. J Clin Neurosci. 2006 Jun;13(5):550-7.
39. Henry JA, Loovis C, Montero M, et al. Randomized clinical trial: group counseling based on tinnitus retraining therapy. J Rehabil Res Dev. 2007;44(1):21-32.
40. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg. 1996 Feb;122(2):143-8.
41. Kuk FK, Tyler RS, Russell D, et al. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear. 1990 Dec;11(6):434-45.
42. Caffier PP, Haupt H, Scherer H, et al. Outcomes of long-term outpatient tinnitus-coping therapy: psychometric changes and value of tinnitus-control instruments. Ear Hear. 2006 Dec;27(6):619-27.
43. Langguth B, Elgoyhen AB. Current pharmacological treatments for tinnitus. Expert Opin Pharmacother. 2012 Dec;13(17):2495-509.
44. Cima RF, Maes IH, Joore MA, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9.
45. Hobson J, Chisholm E, El Refaie A. Sound therapy (masking) in the management of tinnitus in adults. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD006371.
46. Seidman MD, Moneysmith M. Nutraceuticals and herbal supplements. In: Campbell KCM, Belmont M, eds. Pharmacology and ototoxicity for audiologists. New York, NY: Thomson Delmar Learning Publishers; 2005.
47. Robb M, Seidman M. Nutritional supplements for the hearing impaired patient. In: Dereberry MJ, Luxford W, eds. Hearing loss: the otolaryngologists guide to amplification. San Diego, CA: Plural Publishishing; 2009.
48. Kim JI, Choi JY, Lee DH, et al. Acupuncture for the treatment of tinnitus: a systematic review of randomized clinical trials. BMC Complement Altern Med. 2012 Jul 17;12:97.
49. Baldo P, Doree C, Molin P, et al. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD003853.
50. Belli H, Belli S, Oktay MF, et al. Psychopathological dimensions of tinnitus and psychopharmacologic approaches in its treatment. Gen Hosp Psychiatry. 2012 May-Jun;34(3):282-9.
51. Tyler RS. Tinnitus treatment. New York, NY: Thieme Medical Publishers; 2006.
52. Henry JA, Zaugg TL, Schechter MA. Clinical guide for audiologic tinnitus management II: Treatment. Am J Audiol. 2005 Jun;14(1):49-70.
53. Martinez-Devesa P, Perera R, Theodoulou M, et al. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD005233.
54. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus: a double-blind study. Arch Otolaryngol Head Neck Surg. 1993 Aug;119(8):842-5.
55. Vernon JA, Meikle MB. Masking devices and alprazolam treatment for tinnitus. Otolaryngol Clin North Am. 2003 Apr;36(2):307-20.
56. Henry JA, Loovis C, Montero M, et al. Randomized clinical trial: group counseling based on tinnitus retraining therapy. J Rehabil Res Dev. 2007;44(1):21-32.
57. Sierpina VS, Wollschlaeger B, Blumenthal M. Ginkgo biloba. Am Fam Physician. 2003 Sep 1;68(5):923-6.
58. Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol Allied Sci. 1999 Jun;24(3):164-7.
59. Holstein N. Ginkgo special extract EGb 761 in tinnitus therapy: an overview of results of completed clinical trials [in German]. Fortschr Med Orig. 2001 Jan 11;118(4):157-64.
60. von Boetticher A. Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatr Dis Treat. 2011;7:441-7.
61. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ. 2001 Jan 13;322(7278):73.
62. Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD003852.
63. Shemesh Z, Attias J, Ornan M, et al. Vitamin B12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss. Am J Otolaryngol. 1993 Mar-Apr;14(2):94-9.
64. Shulman A. Subjective idiopathic tinnitus: a unified plan of management. Am J Otolaryngol. 1992 Mar-Apr;13(2):63-74.
65. Shambaugh GE Jr. Zinc for tinnitus, imbalance, and hearing loss in the elderly. Am J Otol. 1986 Nov;7(6):476-7.
66. Gersdorff M, Robillard T, Stein F, et al. A clinical correlation between hypozincemia and tinnitus. Arch Otorhinolaryngol. 1987;244(3):190-3.
67. Ochi K, Ohashi T, Kinoshita H, et al. The serum zinc level in patients with tinnitus and the effect of zinc treatment [in Japanese]. Nihon Jibiinkoka Gakkai Kaiho. 1997 Sep;100(9):915-9.
68. Paaske PB, Pedersen CB, Kjems G, et al. Zinc in the management of tinnitus: placebo-controlled trial. Ann Otol Rhinol Laryngol. 1991 Aug;100(8):647-9.
69. Person OC, Puga ME, da Silva EM, et al. Zinc supplementation for tinnitus. Cochrane Database Syst Rev. 2016 Nov 23;(11):CD009832.
70. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, et al. Melatonin: nature's most versatile biological signal? FEBS J. 2006 Jul;273(13):2813-38.
71. Lasisi AO, Fehintola FA, Lasisi TJ. The role of plasma melatonin and vitamins C and B12 in the development of idiopathic tinnitus in the elderly. Ghana Med J. 2012 Sep;46(3):152-7.
72. Rosenberg SI, Silverstein H, Rowan PT, et al. Effect of melatonin on tinnitus. Laryngoscope. 1998 Mar;108(3):305-10.
73. Pirodda A, Raimondi MC, Ferri GG. Exploring the reasons why melatonin can improve tinnitus. Med Hypotheses. 2010 Aug;75(2):190-1.
74. DeRidder D, DeMulder G, Seidman M, et al. Auditory cortex stimulation for intratractable tinnitus. In: Sakas D, Kramer E, eds. Neuromodulation. Oxford, UK: Blackwell; 2006.
75. Steenerson RL, Cronin GW. Treatment of tinnitus with electrical stimulation. Otolaryngol Head Neck Surg. 1999 Nov;121(5):511-3.
76. Rubinstein JT, Tyler RS, Johnson A, et al. Electrical suppression of tinnitus with high-rate pulse trains. Otol Neurotol. 2003 May;24(3):478-85.
77. Song JJ, Vanneste S, Van de Heyning P, et al. Transcranial direct current stimulation in tinnitus patients: a systemic review and meta-analysis. ScientificWorldJournal. 2012;2012:427941.
78. Miyamoto RT, Bichey BG. Cochlear implantation for tinnitus suppression. Otolaryngol Clin North Am. 2003 Apr;36(2):345-52.
79. Greimel KV, Meco C, Mair A, et al. How is tinnitus influenced by cochlear implantation [in German]? HNO. 2003 Mar;51(3):226-31.
80. Meeus OM, De Ridder D, Van de Heyning PH. Transcranial magnetic stimulation (TMS) in tinnitus patients. B-ENT. 2009;5(2):89-100.
81. Meng Z, Liu S, Zheng Y, et al. Repetitive transcranial magnetic stimulation for tinnitus. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007946.
82. Muller PA, Pascual-Leone A, Rotenberg A. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with pathologic positive sensory phenomena: a review of literature. Brain Stimul. 2012 Jul;5(3):320-9.
83. Bennett MH, Kertesz T, Perleth M, et al. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD004739.
84. Muehlmeier G, Biesinger E, Maier H. Safety of intratympanic injection of AM-101 in patients with acute inner ear tinnitus. Audiol Neurootol. 2011;16(6):388-97.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台